enow.com Web Search

  1. Ads

    related to: best medication for ms fatigue and weakness treatment guidelines printable

Search results

  1. Results from the WOW.Com Content Network
  2. Management of multiple sclerosis - Wikipedia

    en.wikipedia.org/wiki/Management_of_multiple...

    Multiple sclerosis can cause a variety of symptoms including changes in sensation (hypoesthesia), muscle weakness, abnormal muscle spasms, impaired movement, difficulties with coordination and balance, problems in speech (known as dysarthria) or swallowing , visual problems (nystagmus, optic neuritis, or diplopia), fatigue and acute or chronic ...

  3. Fingolimod - Wikipedia

    en.wikipedia.org/wiki/Fingolimod

    Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, used for the treatment of multiple sclerosis. [4] Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. It has been reported to reduce the rate of ...

  4. Signs and symptoms of multiple sclerosis - Wikipedia

    en.wikipedia.org/wiki/Signs_and_symptoms_of...

    Main symptoms of multiple sclerosis Symptoms and findings in multiple sclerosis. The signs and symptoms of multiple sclerosis (MS) encompass a wide range of neurological and physical manifestations, including vision problems, muscle weakness, coordination difficulties, and cognitive impairment, varying significantly in severity and progression among individuals.

  5. New treatment may stop and potentially reverse some nerve ...

    www.aol.com/treatment-may-stop-potentially...

    Multiple sclerosis (MS) is a chronic disease of the nervous system that can lead to muscle weakness, vision loss, and paralysis. It occurs when the immune system attacks the myelin sheath that ...

  6. Multiple sclerosis drug pipeline - Wikipedia

    en.wikipedia.org/wiki/Multiple_sclerosis_drug...

    Fingolimod (Gilenya), an oral treatment and the first oral therapy approved for multiple sclerosis. Siponimod (Mayzent), oral. Approved in March 2019 for CIS, RRMS and SPMS [11] [12] Ozanimod: oral. It was approved by the FDA in March 2020 with the trade name Zeposia [13] [14] [15] Ponesimod (Ponvory) Five monoclonal antibodies: Alemtuzumab ...

  7. Trial to assess best course of treatment for patients with MS

    www.aol.com/trial-assess-best-course-treatment...

    The trial will lead to the creation of 19 sites around the country where this treatment can be delivered, which will increase the UK capacity to offer the treatment for MS patients.

  1. Ads

    related to: best medication for ms fatigue and weakness treatment guidelines printable